Article Information
History
- December 27, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Serdar Durdagi1,*,
- Timucin Avsar2,
- Muge Didem Orhan2,
- Muge Serhatli3,
- Bertan Koray Balcioglu3,
- Hasan Umit Ozturk3,
- Alisan Kayabolen4,
- Yuksel Cetin3,
- Seyma Aydinlik3,
- Tugba Bagci-Onder4,
- Saban Tekin3,
- Hasan Demirci5,
- Mustafa Guzel6,
- Atilla Akdemir7,
- Seyma Calis2,8,
- Lalehan Oktay1,
- Ilayda Tolu1,
- Yasar Enes Butun6,
- Ece Erdemoglu1,
- Alpsu Olkan1,
- Nurettin Tokay3,
- Şeyma Işık3,
- Aysenur Ozcan1,
- Elif Acar1,
- Sehriban Buyukkilic1 and
- Yesim Yumak1
- 1Computational Biology and Molecular Simulations Laboratory, Department of Biophysics, School of Medicine, Bahçeşehir University, Istanbul, Turkey
- 2Department of Medical Biology, School of Medicine, Bahçeşehir University, Istanbul, Turkey
- 3The Scientific and Technological Research Council of Turkey (TÜBITAK) Marmara Research Center (MAM), Genetic Engineering and Biotechnology Institute, 41470 Gebze Kocaeli
- 4Brain Cancer Research and Therapy Laboratory, Koç University School of Medicine, 34450 Istanbul, Turkey
- 5Department of Molecular Biology and Genetics, Koç University, 34450, Istanbul, Turkey
- 6Istanbul Medipol University, International School of Medicine, Department of Medical Pharmacology, Istanbul, Turkey
- 7Bezmialem Vakif University, Computer-aided Drug Discovery Laboratory, Department of Pharmacology, Faculty of Pharmacy, Istanbul, Turkey
- 8Department of Molecular Biology-Genetics and Biotechnology, Istanbul Technical University, 34485, Istanbul, Turkey
- ↵*E-mail: serdar.durdagi{at}med.bau.edu.tr; Durdagi Research Group (DRG) durdagilab.com
Posted December 27, 2020.
The neutralization effect of Montelukast on SARS-CoV-2 is shown by multiscale in silico simulations and combined in vitro studies
